Madison Vaccines
Madison Vaccines Incorporated develops vaccines for patients with prostate cancer and a test to identify such patients
About Madison Vaccines
Madison Vaccines, Inc. (MVI) is a biotechnology company focused on developing advanced immunotherapies for prostate cancer. The company specializes in DNA plasmid immunotherapies and combination therapies designed to improve the effectiveness of existing treatments and delay disease progression. MVI serves a diverse range of clients including patients, clinicians, and pharmaceutical partners. Operating in the oncology market, MVI aims to provide innovative solutions that enhance the quality of life for men battling prostate cancer.
MVI's business model revolves around the development and clinical testing of their proprietary immunotherapies. They generate revenue through partnerships with pharmaceutical companies, clinical trials, and potentially through the commercialization of their therapies. By combining their immunotherapies with PD-1 inhibitors and AR axis inhibitors, MVI aims to maximize the clinical value of standard care therapies and drive their adoption in the medical community.
The company is committed to aggressive research and development, ensuring that their therapies are safe and effective for patients at all stages of prostate cancer. MVI's innovative approach not only focuses on treating the disease but also on preserving the quality of life for patients.
Source: Dealroom company dataNews
Open roles
Madison Vaccines in the Menomonie ecosystem
The Madison Vaccines office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Venture Investors Health Fund
WARF Ventures- IPInvestment Partners
State of Wisconsin Investment Board- VMVenture Management
Wisconsin Investment Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Madison Vaccines on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Madison Vaccines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

